In vitro effects of three iron chelators on mitogen-activated lymphocytes: Identification of differences in their mechanisms of action

This publication has 28 references indexed in Scilit:

• Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes
  International Journal of Immunopharmacology, 1991
• Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing Link
  Annual Review of Immunology, 1990
• T-Cell Chemiluminescence.
  Scandinavian Journal of Immunology, 1989
• The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin
  Inflammation Research, 1989
• Cyclooxygenase and lipoxygenase inhibitors act differently on oxidative product formation by immune mononuclear cells: A flow cytometric investigation
  International Journal of Immunopharmacology, 1989
• Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K‐562 and U‐937 cell lines induced by chelators and their iron complexes
  European Journal of Haematology, 1987
• Cytotoxic and DNA‐inhibitory effects of iron chelators on human leukaemic cell lines
  Hematological Oncology, 1986
• Estimation of nonproliferating cells in the neural retina of embryonic chicks by flow cytometry
  Cytometry, 1985
• Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192
  Inflammation Research, 1982
• Superoxide‐dependent formation of hydroxyl radicals in the presence of iron chelates
  FEBS Letters, 1978